Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fagan

Showing results (471-480 of 489) with videos related to

Pageof 49
Sort By:
Neurobiology of Disease|June 12, 2020
Serum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer's diseaseStephanie A Schultz, Jeremy F Strain, Adedamola Adedokun, et al.
Acta Neuropathologica|March 2, 2017
Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiersYuetiva Deming, Zeran Li, Manav Kapoor, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 22, 2021
Modeling autosomal dominant Alzheimer's disease with machine learningPatrick H Luckett, Austin McCullough, Brian A Gordon, et al.
Brain : a Journal of Neurology|May 17, 2022
Autosomal dominant and sporadic late onset Alzheimer's disease share a common in vivo pathophysiologyJohn C Morris, Michael Weiner, Chengjie Xiong, et al.
Brain : a Journal of Neurology|February 21, 2018
Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer's diseaseNicolai Franzmeier, Emrah Düzel, Frank Jessen, et al.
Acta Neuropathologica|July 4, 2018
Sex-specific genetic predictors of Alzheimer's disease biomarkersYuetiva Deming, Logan Dumitrescu, Lisa L Barnes, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 5, 2023
Longitudinal head-to-head comparison of <sup>11</sup>C-PiB and <sup>18</sup>F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer's diseaseCharles D Chen, Austin McCullough, Brian Gordon, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 7, 2013
Regional variability of imaging biomarkers in autosomal dominant Alzheimer's diseaseTammie L S Benzinger, Tyler Blazey, Clifford R Jack, et al.
Aging Cell|June 9, 2023
Location of pathogenic variants in PSEN1 impacts progression of cognitive, clinical, and neurodegenerative measures in autosomal-dominant Alzheimer's diseaseStephanie A Schultz, Zahra Shirzadi, Aaron P Schultz, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 26, 2023
Cerebrospinal fluid biomarkers in the Longitudinal Early-onset Alzheimer's Disease StudyJeffrey L Dage, Ani Eloyan, Maryanne Thangarajah, et al.
Pageof 49

Showing results (471-480 of 489) with videos related to

Sort By:
Pageof 49
Neurobiology of Disease|June 12, 2020
Serum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer's diseaseStephanie A Schultz, Jeremy F Strain, Adedamola Adedokun, et al.
Acta Neuropathologica|March 2, 2017
Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiersYuetiva Deming, Zeran Li, Manav Kapoor, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 22, 2021
Modeling autosomal dominant Alzheimer's disease with machine learningPatrick H Luckett, Austin McCullough, Brian A Gordon, et al.
Brain : a Journal of Neurology|May 17, 2022
Autosomal dominant and sporadic late onset Alzheimer's disease share a common in vivo pathophysiologyJohn C Morris, Michael Weiner, Chengjie Xiong, et al.
Brain : a Journal of Neurology|February 21, 2018
Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer's diseaseNicolai Franzmeier, Emrah Düzel, Frank Jessen, et al.
Acta Neuropathologica|July 4, 2018
Sex-specific genetic predictors of Alzheimer's disease biomarkersYuetiva Deming, Logan Dumitrescu, Lisa L Barnes, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 5, 2023
Longitudinal head-to-head comparison of <sup>11</sup>C-PiB and <sup>18</sup>F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer's diseaseCharles D Chen, Austin McCullough, Brian Gordon, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 7, 2013
Regional variability of imaging biomarkers in autosomal dominant Alzheimer's diseaseTammie L S Benzinger, Tyler Blazey, Clifford R Jack, et al.
Aging Cell|June 9, 2023
Location of pathogenic variants in PSEN1 impacts progression of cognitive, clinical, and neurodegenerative measures in autosomal-dominant Alzheimer's diseaseStephanie A Schultz, Zahra Shirzadi, Aaron P Schultz, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 26, 2023
Cerebrospinal fluid biomarkers in the Longitudinal Early-onset Alzheimer's Disease StudyJeffrey L Dage, Ani Eloyan, Maryanne Thangarajah, et al.
Pageof 49